Biotech Culture Change Operations 
Kotter Inc.
SEPTEMBER 23, 2024
As Starbucks and Chipotle navigate CEO transitions, Nick Petschek of Kotter shares how organisations can empower their leaders during leadership changes.
Kotter Inc.
MARCH 17, 2025
The post Building Adaptability in the Pharmaceutical Industry appeared first on Kotter International Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kotter Inc.
FEBRUARY 13, 2025
The post Beyond the deal: unlocking sustainable success in pharma M&A appeared first on Kotter International Inc.
Kotter Inc.
APRIL 24, 2025
As leaders look toward the future, the companies that will outpace and outperform their competitors will be those that can embrace and scale adaptability and agility in their operations.
Kotter Inc.
MAY 26, 2025
Uncertainty isnt necessarily badtimes of change and disruption are filled with opportunities to do things differently and better. If new regulatory requirements are disrupting the way the business has operated, it will do so for the whole industry and create an opportunity to shift the landscape and come out on top.
Kotter Inc.
FEBRUARY 13, 2025
After the pharmaceutical industrys muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.
Kotter Inc.
NOVEMBER 25, 2024
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.
Expert insights. Personalized for you.
97 
Let's personalize your content